【News】The core equipment of Yinfeng Life Extension Plan was unveiled at the ASEAN Expo
Release time:
2022-09-22
From September 16 to 19, 2022, the 19th China-ASEAN Expo Advanced Technology Exhibition (hereinafter referred to as the "ASEAN Expo") was hosted by the People's Government of Guangxi Zhuang Autonomous Region of the Ministry of Science and Technology of the People's Republic of China and organized by the China-ASEAN Technology Transfer Center of the Department of Science and Technology of Guangxi Zhuang Autonomous Region. At the official opening of the Nanning International Convention and Exhibition Center, the Cryogenic Medicine Center of Shandong Yinfeng Life Science Research Institute (hereinafter referred to as the Academy of Biological Sciences) made a collective appearance with many powerful products and became the focus of the exhibition.
As a key recommendation unit of the Organizing Committee of the 19th China-ASEAN Expo, the Cryogenic Medicine Center of the Academy of Biological Sciences exhibited the program cryometer and cryogenic cold therapy instrument for the first time in the advanced technology exhibition hall of the ASEAN Expo, attracting leaders at all levels, domestic and foreign exhibitors to visit the booth for guidance, and also won many media attention and reports, becoming one of the focuses of the advanced technology pavilion, and the atmosphere was warm.
The programmed cooler equipment exhibited by the Cryogenic Medicine Center of the Academy of Biological Sciences was deeply loved by the audience and attracted many visitors to stop and understand. The equipment is independently developed by Yinfeng, high-precision, large-span human cryopreservation program cooling equipment, which uses jet vortex pressure, equipped with more than 10 solenoid valves and temperature sensors, computer program precise control, to ensure rapid and balanced cooling of samples, is the only equipment in the world that can continue to cool the body evenly and continuously to below -190 °C, to avoid damage to the body in the cooling process, suitable for effective cooling of multi-scale cells, tissues, organs and even the human body sensitive to temperature changes. In September 2021, the device was exported to the Australian cryonics facility.
The Human Cryopreservation and Resuscitation Research Project is the most cutting-edge, core and complex life science research project in Yinfeng's life extension program. Through interdisciplinary research such as cryobiology, cryomedicine, thermophysics and clinical medicine, the program will cryopreserve the entire human body after the clinical death of volunteers, slow down or even suspend the metabolism of cells, tissues and organs that are still alive in the human body, and block the process of functional failure and biological "death". Protecting the integrity of cell structures and the functionality of biochemical pathways, we look forward to suspending and restarting the physiological and biochemical functions of human tissues and organs, so that life can continue. In addition, Yinfeng's life extension plan also includes the research project of tissue and organ cryopreservation and resuscitation, which is committed to using advanced cryogenic biomedical technology to carry out research on cryopreservation, resuscitation and clinical transformation application of cells, tissues and organs.
This appearance at the ASEAN Expo has made Yinfeng's life extension plan the focus of attention again. The Institute of Biological Sciences will continue to uphold the organizational mission of "dedicating medical technology to ensure human health" and inherit the brand power of Yinfeng. In the fields of cryogenic medicine, biotechnology, life sciences, etc., we will explore and innovate, promote the transformation of scientific research achievements, create greater value for the cause of national health with practical actions, and make more contributions to the construction of a healthy China.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
